CONTEXT: Most patients with serious and life-limiting illness experience pain at some point in the illness trajectory. OBJECTIVES: To describe baseline pain management practices for imminently dying patients in Veterans Administration Medical Centers (VAMCs) and examine factors associated with these processes, including presence of opioid orders at the time of death and medication administration in the last seven days, 48 hours, and 24 hours of life. METHODS: Data on orders and administration of opioid pain medication at the end of life were abstracted from the medical records of veterans who died in six VAMC hospitals in 2005. RESULTS: Of 1068 patient records, 686 (64.2%) had an active order for an opioid medication at the time of death. Of these, 69.8% of patients had received the medication at some time within the last seven days of life, 61.2% within the last 48 hours, and 47.0% within the last 24 hours. In multivariable models, presence of an order for opioid pain medication at the time of death and administration within the last 24 hours were both significantly associated with having a Do Not Resuscitate (DNR) order (P < 0.0001/0.0002), terminal condition (P < 0.0001/< 0.0001), family presence (P < 0.0001/0.0023), location of death (P = 0.003/0.0005), and having pain noted in the care plan (P = 0.0073/0.0007). CONCLUSION: Findings indicate a need for improving availability of opioids for end-of-life care in the inpatient setting. Modifiable factors, such as family presence and goals-of-care discussions, suggest potential targets for intervention to improve recognition of the dying process and proactive planning for pain control. Published by Elsevier Inc.
CONTEXT: Most patients with serious and life-limiting illness experience pain at some point in the illness trajectory. OBJECTIVES: To describe baseline pain management practices for imminently dying patients in Veterans Administration Medical Centers (VAMCs) and examine factors associated with these processes, including presence of opioid orders at the time of death and medication administration in the last seven days, 48 hours, and 24 hours of life. METHODS: Data on orders and administration of opioid pain medication at the end of life were abstracted from the medical records of veterans who died in six VAMC hospitals in 2005. RESULTS: Of 1068 patient records, 686 (64.2%) had an active order for an opioid medication at the time of death. Of these, 69.8% of patients had received the medication at some time within the last seven days of life, 61.2% within the last 48 hours, and 47.0% within the last 24 hours. In multivariable models, presence of an order for opioid pain medication at the time of death and administration within the last 24 hours were both significantly associated with having a Do Not Resuscitate (DNR) order (P < 0.0001/0.0002), terminal condition (P < 0.0001/< 0.0001), family presence (P < 0.0001/0.0023), location of death (P = 0.003/0.0005), and having pain noted in the care plan (P = 0.0073/0.0007). CONCLUSION: Findings indicate a need for improving availability of opioids for end-of-life care in the inpatient setting. Modifiable factors, such as family presence and goals-of-care discussions, suggest potential targets for intervention to improve recognition of the dying process and proactive planning for pain control. Published by Elsevier Inc.
Authors: Katrina J Lin; Andrea Ching; Kyle P Edmonds; Eric J Roeland; Carolyn Revta; Joseph D Ma; Rabia S Atayee Journal: J Palliat Med Date: 2015-06-24 Impact factor: 2.947
Authors: Meagan E Cea; M Cary Reid; Charles Inturrisi; Lisa R Witkin; Holly G Prigerson; Yuhua Bao Journal: J Pain Symptom Manage Date: 2016-09-29 Impact factor: 3.612
Authors: R Douglas Bruce; Jessica Merlin; Paula J Lum; Ebtesam Ahmed; Carla Alexander; Amanda H Corbett; Kathleen Foley; Kate Leonard; Glenn Jordan Treisman; Peter Selwyn Journal: Clin Infect Dis Date: 2017-10-30 Impact factor: 9.079
Authors: Marc Tanghe; Nele Van Den Noortgate; Lara Pivodic; Luc Deliens; Bregje Onwuteaka-Philipsen; Katarzyna Szczerbinska; Harriet Finne-Soveri; Danni Collingridge-Moore; Giovanni Gambassi; Lieve Van den Block; Ruth Piers Journal: Eur J Public Health Date: 2019-02-01 Impact factor: 3.367